What is Internal Balance?
Internal Balance operates at the intersection of biotechnology and personalized medicine, providing comprehensive health improvement programs designed to address chronic conditions. The company distinguishes itself through the integration of DNA-based detoxification protocols and bespoke medical services, catering to a demographic that has historically found limited success with conventional medical interventions. By prioritizing a strategic, iterative approach to healing, Internal Balance restores the body's natural capacity for recovery, serving a diverse client base that includes families and individuals navigating complex health challenges. Their model relies on constant evaluation and high-touch support, establishing a unique value proposition in the wellness industry.
How much funding has Internal Balance raised?
Internal Balance has raised a total of $53K across 1 funding round:
Debt
$53K
Debt (2021): $53K with participation from PPP
Key Investors in Internal Balance
PPP
Public-Private Partnership
What's next for Internal Balance?
With the infusion of this recent capital, Internal Balance is poised to accelerate its operational footprint and enhance its proprietary diagnostic capabilities. The strategic focus will likely shift toward expanding its clinical infrastructure and refining its DNA-based analytical tools to accommodate a larger patient volume. As the company matures through its current growth stage, the emphasis will remain on scaling its personalized support model while maintaining the high-fidelity outcomes that define its brand. Future initiatives may include broader market penetration and the potential integration of advanced health-tracking technologies to further solidify its competitive advantage in the chronic health recovery market.
See full Internal Balance company page
